UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 
 FORM 10-K/A
 Amendment No. 1
 
 þ
    
    Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 For the fiscal year ended December 31, 2008
 o
    
    Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 For the Transition Period from  to
 Commission File Number 001-33043
 
 ImaRx Therapeutics, Inc.
 (Exact Name of Registrant as Specified in Its Charter)
 
 Delaware
(State or Other Jurisdiction of 
Incorporation or Organization)
    
    86-0974730
(I.R.S. Employer
Identification No.)ImaRx Therapeutics, Inc. 
c/o Stoel Rives LLP 
201 S. Main Street, Suite 1100Salt Lake City, Utah
(Address of Principal Executive Offices)
    
    84111
(Zip Code)
 (801) 578-6962
(Registrants Telephone Number, Including Area Code)
 Securities registered pursuant to Section 12(b) of the Act:
 None
 Securities registered pursuant to Section 12(g) of the Act:
 Common Stock, $0.0001 par value  (Title of Each Class)
 YES o NO þ
 YES o NO þ
 YES þ NO o
 YES o NO o
 Form 10-K. þ
  Large Accelerated filer o
    
    Accelerated filer o
    
    Non-accelerated filer o
(Do not check if a smaller reporting company)
    
    Smaller reporting company þ
 YES o NO þ




---



##### 



EXPLANATORY NOTE




---



##### 



PART IV
 ITEM 15. Exhibits and Financial Statement Schedules
  Financial Statements:
   Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date3.1
    
    
    Fourth Amended and Restated
Certificate of Incorporation of the
registrant
    
    
    
    S-1
    
    
    3.1
    
    
    333-142646
    
    5/4/20073.2
    
    
    Amendment to Certificate of
Incorporation of the registrant to
effect a six-for-ten reverse stock
split
    
    
    
    S-1
    
    
    3.2
    
    
    333-142646
    
    5/4/20073.3
    
    
    Second Amendment to Certificate of
Incorporation of the registrant to
effect a one-for-three reverse
stock split
    
    
    
    S-1
    
    
    3.3
    
    
    333-142646
    
    5/4/20073.4
    
    
    Amended and Restated Certificate of
Incorporation of the registrant
    
    
    
    S-1
    
    
    3.4
    
    
    333-142646
    
    5/4/20073.5
    
    
    Bylaws of the registrant, as amended
    
    
    
    S-1
    
    
    3.5
    
    
    333-142646
    
    5/4/20073.6
    
    
    Amended and Restated Bylaws of the
registrant
    
    
    
    S-1
    
    
    3.6
    
    
    333-142646
    
    5/4/20074.1
    
    
    Specimen certificate evidencing
shares of common stock
    
    
    
    S-1
    
    
    4.1
    
    
    333-142646
    
    5/4/200710.1*
    
    Form of Indemnification Agreement
entered into between the registrant
and each of its directors and
officers
    
    
    
    S-1
    
    
    10.1
    
    
    333-142646
    
    5/4/200710.2
    
    
    Second Amended and Restated
Investors Rights Agreement, dated
April 14, 2006, by and among the
registrant and certain stockholders
    
    
    
    S-1
    
    
    10.2
    
    
    333-142646
    
    5/4/200710.3*
    
    2000 Stock Plan and related
agreements
    
    
    
    S-1
    
    
    10.3
    
    
    333-142646
    
    5/4/200710.4*
    
    2007 Performance Incentive Plan and
related agreements
    
    
    
    S-1
    
    
    10.4
    
    
    333-142646
    
    5/4/200710.5*
    
    Bonus Plan
    
    
    
    S-1
    
    
    10.5
    
    
    333-142646
    
    5/4/200710.6
    
    
    License Agreement, dated January 4,
2005, between the registrant and
Dr. med. Reinhard Schlief
    
    
    
    S-1
    
    
    10.6
    
    
    333-142646
    
    5/4/2007
  3




---



##### 



Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date10.7
    
    
    Exclusive Sublicense Agreement,
dated October 10, 2003, between the
registrant and UNEMED Corporation
    
    
    
    S-1
    
    
    10.7
    
    
    333-142646
    
    5/4/200710.8
    
    
    Assignment, Assumption and License
Agreement, dated October 7, 1999,
between the registrant and
Bristol-Myers Squibb Medical
Imaging, Inc. (as successor to
DuPont Contrast Imaging, Inc.)
dated October 7, 1999, and
amendments thereto
    
    
    
    S-1
    
    
    10.8
    
    
    333-142646
    
    5/4/200710.9
    
    
    License Agreement, dated February
10, 2006, between the registrant
and the University of Arkansas for
Medical Sciences
    
    
    
    S-1
    
    
    10.9
    
    
    333-142646
    
    5/4/200710.10
    
    
    Asset Purchase Agreement, dated
April 10, 2006, between the
registrant and Abbott Laboratories,
and amendments thereto
    
    
    
    S-1
    
    
    10.10
    
    
    333-142646
    
    5/4/200710.11
    
    
    Escrow Agreement, dated April 14,
2006, between the registrant and
Abbott Laboratories
    
    
    
    S-1
    
    
    10.11
    
    
    333-142646
    
    5/4/200710.12
    
    
    Inventory Trademark License
Agreement, dated April 14, 2006,
between the registrant and Abbott
Laboratories
    
    
    
    S-1
    
    
    10.12
    
    
    333-142646
    
    5/4/200710.13
    
    
    Security Agreement, dated April 14,
2006, between the registrant and
Abbott Laboratories
    
    
    
    S-1
    
    
    10.13
    
    
    333-142646
    
    5/4/200710.14
    
    
    Secured Promissory Note, dated
April 14, 2006, between the
registrant and Abbott Laboratories
    
    
    
    S-1
    
    
    10.14
    
    
    333-142646
    
    5/4/200710.15
    
    
    Second Amended Executive Employment
Agreement, dated May 15, 2006,
between the registrant and Evan C.
Unger
    
    
    
    S-1
    
    
    10.15
    
    
    333-142646
    
    5/4/200710.16
    
    
    Consulting Agreement, dated October
20, 2006, between the registrant
and Evan C. Unger
    
    
    
    S-1
    
    
    10.16
    
    
    333-142646
    
    5/4/200710.17
    
    
    Confidential Separation Agreement
and Mutual General Release of All
Claims, dated November 28, 2006,
between the registrant and Evan C.
Unger
    
    
    
    S-1
    
    
    10.17
    
    
    333-142646
    
    5/4/200710.18*
    
    Consulting Agreement, dated April
11, 2005, between the registrant
and Greg Cobb
    
    
    
    S-1
    
    
    10.18
    
    
    333-142646
    
    5/4/2007
  4




---



##### 



Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date10.19*
    
    Amended Executive Employment
Agreement, dated February 1, 2007,
between the registrant and Greg
Cobb
    
    
    
    S-1
    
    
    10.19
    
    
    333-142646
    
    5/4/200710.20*
    
    Amended Executive Employment
Agreement, dated February 1, 2007,
between the registrant and Bradford
A. Zakes
    
    
    
    S-1
    
    
    10.20
    
    
    333-142646
    
    5/4/200710.21
    
    
    Agreement, dated March 31, 2006, by
and among the registrant, John A.
Moore and Edson Moore Healthcare
Ventures
    
    
    
    S-1
    
    
    10.21
    
    
    333-142646
    
    5/4/200710.22
    
    
    Subscription Agreement and Investor
Questionnaire, dated March 2004,
between the registrant and each of
the signatory investors, offering
price $2.00 per share
    
    
    
    S-1
    
    
    10.22
    
    
    333-142646
    
    5/4/200710.23
    
    
    Subscription Agreement and Investor
Questionnaire, dated December 2004,
between the registrant and each of
the signatory investors, offering
price $3.00 per share
    
    
    
    S-1
    
    
    10.23
    
    
    333-142646
    
    5/4/200710.24
    
    
    Subscription Agreement and Investor
Questionnaire, dated September and
October 2004, between the
registrant and each of the
signatory investors, offering price
$4.00 per share
    
    
    
    S-1
    
    
    10.24
    
    
    333-142646
    
    5/4/200710.25
    
    
    Commercial Lease  Triple Net,
dated November 1, 2002, between the
registrant and ImaRx Investments
L.L.C.
    
    
    
    S-1
    
    
    10.25
    
    
    333-142646
    
    5/4/200710.26
    
    
    Standard Commercial  Industrial
Lease, dated December 30, 1997,
between the registrant and Tucson
Tech Park and addenda thereto
    
    
    
    S-1
    
    
    10.26
    
    
    333-142646
    
    5/4/200710.27
    
    
    Note Extension and Amendment
Agreement, dated October 25, 2007,
between the registrant and Abbott
Laboratories
    
    
    
    8-K
    
    
    10.1
    
    
    001-33043
    
    10/26/200710.28*
    
    Amendment No. 2 to Executive
Employment Agreement dated as of
January 1, 2008 by and between the
Company and Bradford A. Zakes
    
    
    
    8-K
    
    
    10.1
    
    
    001-33043
    
    2/7/200810.29*
    
    Amendment No. 2 to Executive
Employment Agreement dated as of
January 1, 2008 by and between the
Company and Greg Cobb
    
    
    
    8-K
    
    
    10.2
    
    
    001-33043
    
    2/7/2008
  5




---



##### 



Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date10.30*
    
    Executive Employment Agreement
dated as of January 1, 2008 by and
between the Company and Garen
Manvelian
    
    
    
    8-K
    
    
    10.3
    
    
    001-33043
    
    2/7/200810.31*
    
    Executive Employment Agreement
dated as of January 1, 2008 by and
between the Company and Kevin
Ontiveros
    
    
    
    8-K
    
    
    10.4
    
    
    001-33043
    
    2/7/200810.32
    
    
    Separation and Release of Claims
Agreement with Greg Cobb
    
    
    
    8-K
    
    
    10.2
    
    
    001-33043
    
    6/10/200810.33
    
    
    Separation and Release of Claims
Agreement with Kevin Ontiveros
    
    
    
    8-K
    
    
    10.4
    
    
    001-33043
    
    6/10/200810.33
    
    
    Consulting Agreement with Greg Cobb
    
    
    
    8-K
    
    
    10.3
    
    
    001-33043
    
    6/10/200810.34
    
    
    Amended Executive Employment 
Agreement with Brad Zakes
    
    
    
    8-K
    
    
    10.1
    
    
    001-33043
    
    6/27/200810.35
    
    
    Commercial Lease  dated December
10, 2007, between the registrant
and Cambric Partners
    
    
    
    10-K
    
    
    10.32
    
    
    001-33043
    
    8/31/200810.36
    
    
    Sublease Agreement  dated
December 29, 2008 between the
Registrant and Koronis
Pharmaceuticals, Inc
    
    
    
    10-K
    
    
    10.36
    
    
    001-33043
    
    3/09/200923.1
    
    
    Consent of Independent Registered
Public Accounting Firm  McKennon,
Wilson & Morgan, LLP
    
    
    
    10-K
    
    
    23.1
    
    
    001-33043
    
    3/09/200923.2
    
    
    Consent of Independent Registered
Public Accounting Firm  Ernst &
Young, LLP
    
    
    
    10-K
    
    
    23.2
    
    
    001-33043
    
    3/09/200924.1
    
    
    Power of Attorney (included in the
signature page hereto)
    
    
    
    10-K
    
    
    24.1
    
    
    001-33043
    
    3/09/200931.1
    
    

Certification
of Principal Executive
Officer pursuant to Exchange Act
Rules 13a-14(a) and 15d-14(a), as
adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002
    
    X31.2
    
    

Certification
of Principal Financial
Officer pursuant to Exchange Act
Rules 13a-14(a) and 15d-14(a), as
adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002
    
    X32
    
    
    Certification of Chief Executive
Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant
to Section 906 of the
Sarbanes-Oxley Act of 2002
    
    
    
    10-K
    
    
    32
    
    
    001-33043
    
    3/09/2009
   6




---



##### 



SIGNATURES
  IMARX THERAPEUTICS, INC.By:
    /s/ Richard LoveRichard LoveChairman of the BoardDecember 29, 2009Date  Signature
    
    Title
    
    Date/s/ Richard Love
Richard Love
    
    Chairman of the Board and Director
    
    December 29, 2009* /s/ Richard Otto
Richard Otto
    
    Director
    
    December 29, 2009* /s/ Thomas W. Pew
Thomas W. Pew
    
    Director
    
    December 29, 2009* /s/ Philip Ranker
Philip Ranker
    
    Director
    
    December 29, 2009* /s/ James M. Strickland
James M. Strickland
    
    Director
    
    December 29, 2009* By: /s/ Richard Love
ATTORNEY-IN-FACT
  7




---



##### 



Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date3.1
    
    
    Fourth Amended and Restated
Certificate of Incorporation of the
registrant
    
    
    
    S-1
    
    
    3.1
    
    
    333-142646
    
    5/4/20073.2
    
    
    Amendment to Certificate of
Incorporation of the registrant to
effect a six-for-ten reverse stock
split
    
    
    
    S-1
    
    
    3.2
    
    
    333-142646
    
    5/4/20073.3
    
    
    Second Amendment to Certificate of
Incorporation of the registrant to
effect a one-for-three reverse
stock split
    
    
    
    S-1
    
    
    3.3
    
    
    333-142646
    
    5/4/20073.4
    
    
    Amended and Restated Certificate of
Incorporation of the registrant
    
    
    
    S-1
    
    
    3.4
    
    
    333-142646
    
    5/4/20073.5
    
    
    Bylaws of the registrant, as amended
    
    
    
    S-1
    
    
    3.5
    
    
    333-142646
    
    5/4/20073.6
    
    
    Amended and Restated Bylaws of the
registrant
    
    
    
    S-1
    
    
    3.6
    
    
    333-142646
    
    5/4/20074.1
    
    
    Specimen certificate evidencing
shares of common stock
    
    
    
    S-1
    
    
    4.1
    
    
    333-142646
    
    5/4/200710.1*
    
    Form of Indemnification Agreement
entered into between the registrant
and each of its directors and
officers
    
    
    
    S-1
    
    
    10.1
    
    
    333-142646
    
    5/4/200710.2
    
    
    Second Amended and Restated
Investors Rights Agreement, dated
April 14, 2006, by and among the
registrant and certain stockholders
    
    
    
    S-1
    
    
    10.2
    
    
    333-142646
    
    5/4/200710.3*
    
    2000 Stock Plan and related
agreements
    
    
    
    S-1
    
    
    10.3
    
    
    333-142646
    
    5/4/200710.4*
    
    2007 Performance Incentive Plan and
related agreements
    
    
    
    S-1
    
    
    10.4
    
    
    333-142646
    
    5/4/200710.5*
    
    Bonus Plan
    
    
    
    S-1
    
    
    10.5
    
    
    333-142646
    
    5/4/200710.6
    
    
    License Agreement, dated January 4,
2005, between the registrant and
Dr. med. Reinhard Schlief
    
    
    
    S-1
    
    
    10.6
    
    
    333-142646
    
    5/4/200710.7
    
    
    Exclusive Sublicense Agreement,
dated October 10, 2003, between the
registrant and UNEMED Corporation
    
    
    
    S-1
    
    
    10.7
    
    
    333-142646
    
    5/4/200710.8
    
    
    Assignment, Assumption and License
Agreement, dated October 7, 1999,
between the registrant and
Bristol-Myers Squibb Medical
Imaging, Inc. (as successor to
DuPont Contrast Imaging, Inc.)
dated October 7, 1999, and
amendments thereto
    
    
    
    S-1
    
    
    10.8
    
    
    333-142646
    
    5/4/2007




---



##### 



Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date10.9
    
    
    License Agreement, dated February
10, 2006, between the registrant
and the University of Arkansas for
Medical Sciences
    
    
    
    S-1
    
    
    10.9
    
    
    333-142646
    
    5/4/200710.10
    
    
    Asset Purchase Agreement, dated
April 10, 2006, between the
registrant and Abbott Laboratories,
and amendments thereto
    
    
    
    S-1
    
    
    10.10
    
    
    333-142646
    
    5/4/200710.11
    
    
    Escrow Agreement, dated April 14,
2006, between the registrant and
Abbott Laboratories
    
    
    
    S-1
    
    
    10.11
    
    
    333-142646
    
    5/4/200710.12
    
    
    Inventory Trademark License
Agreement, dated April 14, 2006,
between the registrant and Abbott
Laboratories
    
    
    
    S-1
    
    
    10.12
    
    
    333-142646
    
    5/4/200710.13
    
    
    Security Agreement, dated April 14,
2006, between the registrant and
Abbott Laboratories
    
    
    
    S-1
    
    
    10.13
    
    
    333-142646
    
    5/4/200710.14
    
    
    Secured Promissory Note, dated
April 14, 2006, between the
registrant and Abbott Laboratories
    
    
    
    S-1
    
    
    10.14
    
    
    333-142646
    
    5/4/200710.15
    
    
    Second Amended Executive Employment
Agreement, dated May 15, 2006,
between the registrant and Evan C.
Unger
    
    
    
    S-1
    
    
    10.15
    
    
    333-142646
    
    5/4/200710.16
    
    
    Consulting Agreement, dated October
20, 2006, between the registrant
and Evan C. Unger
    
    
    
    S-1
    
    
    10.16
    
    
    333-142646
    
    5/4/200710.17
    
    
    Confidential Separation Agreement
and Mutual General Release of All
Claims, dated November 28, 2006,
between the registrant and Evan C.
Unger
    
    
    
    S-1
    
    
    10.17
    
    
    333-142646
    
    5/4/200710.18*
    
    Consulting Agreement, dated April
11, 2005, between the registrant
and Greg Cobb
    
    
    
    S-1
    
    
    10.18
    
    
    333-142646
    
    5/4/200710.19*
    
    Amended Executive Employment
Agreement, dated February 1, 2007,
between the registrant and Greg
Cobb
    
    
    
    S-1
    
    
    10.19
    
    
    333-142646
    
    5/4/200710.20*
    
    Amended Executive Employment
Agreement, dated February 1, 2007,
between the registrant and Bradford
A. Zakes
    
    
    
    S-1
    
    
    10.20
    
    
    333-142646
    
    5/4/200710.21
    
    
    Agreement, dated March 31, 2006, by
and among the registrant, John A.
Moore and Edson Moore Healthcare
Ventures
    
    
    
    S-1
    
    
    10.21
    
    
    333-142646
    
    5/4/2007




---



##### 



Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date10.22
    
    
    Subscription Agreement and Investor
Questionnaire, dated March 2004,
between the registrant and each of
the signatory investors, offering
price $2.00 per share
    
    
    
    S-1
    
    
    10.22
    
    
    333-142646
    
    5/4/200710.23
    
    
    Subscription Agreement and Investor
Questionnaire, dated December 2004,
between the registrant and each of
the signatory investors, offering
price $3.00 per share
    
    
    
    S-1
    
    
    10.23
    
    
    333-142646
    
    5/4/200710.24
    
    
    Subscription Agreement and Investor
Questionnaire, dated September and
October 2004, between the
registrant and each of the
signatory investors, offering price
$4.00 per share
    
    
    
    S-1
    
    
    10.24
    
    
    333-142646
    
    5/4/200710.25
    
    
    Commercial Lease  Triple Net,
dated November 1, 2002, between the
registrant and ImaRx Investments
L.L.C.
    
    
    
    S-1
    
    
    10.25
    
    
    333-142646
    
    5/4/200710.26
    
    
    Standard Commercial  Industrial
Lease, dated December 30, 1997,
between the registrant and Tucson
Tech Park and addenda thereto
    
    
    
    S-1
    
    
    10.26
    
    
    333-142646
    
    5/4/200710.27
    
    
    Note Extension and Amendment
Agreement, dated October 25, 2007,
between the registrant and Abbott
Laboratories
    
    
    
    8-K
    
    
    10.1
    
    
    001-33043
    
    10/26/200710.28*
    
    Amendment No. 2 to Executive
Employment Agreement dated as of
January 1, 2008 by and between the
Company and Bradford A. Zakes
    
    
    
    8-K
    
    
    10.1
    
    
    001-33043
    
    2/7/200810.2*9
    
    Amendment No. 2 to Executive
Employment Agreement dated as of
January 1, 2008 by and between the
Company and Greg Cobb
    
    
    
    8-K
    
    
    10.2
    
    
    001-33043
    
    2/7/200810.30*
    
    Executive Employment Agreement
dated as of January 1, 2008 by and
between the Company and Garen
Manvelian
    
    
    
    8-K
    
    
    10.3
    
    
    001-33043
    
    2/7/200810.31*
    
    Executive Employment Agreement
dated as of January 1, 2008 by and
between the Company and Kevin
Ontiveros
    
    
    
    8-K
    
    
    10.4
    
    
    001-33043
    
    2/7/200810.32
    
    
    Separation and Release of Claims
Agreement with Greg Cobb
    
    
    
    8-K
    
    
    10.2
    
    
    001-33043
    
    6/10/200810.33
    
    
    Separation and Release of Claims
Agreement with Kevin Ontiveros
    
    
    
    8-K
    
    
    10.4
    
    
    001-33043
    
    6/10/2008




---



##### 



Incorporated by ReferenceExhibit
    
    
    
    Filed
    
    
    
    ExhibitNo
    
    Exhibit Title
    
    Herewith
    
    Form
    
    No.
    
    File No.
    
    Filing Date10.33
    
    
    Consulting Agreement with Greg Cobb
    
    
    
    8-K
    
    
    10.3
    
    
    001-33043
    
    6/10/200810.34
    
    
    Amended Executive Employment 
Agreement with Brad Zakes
    
    
    
    8-K
    
    
    10.1
    
    
    001-33043
    
    6/27/200810.35
    
    
    Commercial Lease  dated December
10, 2007, between the registrant
and Cambric Partners
    
    
    
    10-K
    
    
    10.32
    
    
    001-33043
    
    8/31/200810.36
    
    
    Sublease Agreement  dated
December 29, 2008 between the
Registrant and Koronis
Pharmaceuticals, Inc
    
    
    
    10-K
    
    
    10.36
    
    
    001-33043
    
    3/09/200923.1
    
    
    Consent of Independent Registered
Public Accounting Firm  McKennon,
Wilson & Morgan, LLP
    
    
    
    10-K
    
    
    23.1
    
    
    001-33043
    
    3/09/200923.2
    
    
    Consent of Independent Registered
Public Accounting Firm  Ernst &
Young, LLP
    
    
    
    10-K
    
    
    23.2
    
    
    001-33043
    
    3/09/200924.1
    
    
    Power of Attorney (included in the
signature page hereto)
    
    
    
    10-K
    
    
    24.1
    
    
    001-33043
    
    3/09/200931.1
    
    

Certification
of Principal Executive
Officer pursuant to Exchange Act
Rules 13a-14(a) and 15d-14(a), as
adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002
    
    X31.2
    
    

Certification
of Principal Financial
Officer pursuant to Exchange Act
Rules 13a-14(a) and 15d-14(a), as
adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002
    
    X32
    
    
    Certification of Chief Executive
Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant
to Section 906 of the
Sarbanes-Oxley Act of 2002
    
    
    
    10-K
    
    
    32
    
    
    001-33043
    
    3/09/2009